SynthesisEuropean journal of clinical pharmacology2016

Comparison of clinical outcomes of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations after tyrosine kinase inhibitors treatment: a meta-analysis.

Miaomiao Sheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.